观察两组患者心脏电生理指标、血流动力学恢复、正性肌力药物用量、心肌细胞超微结构和心肌酶浓度变化等。
Cardiac electrophysiologic data, recovery of hemodynamics, inotropic medicine dosage, myocardial ultrastructural changes and concentration of myocardial enzymes were assessed.
IWMI合并RVMI患者需要更多的容量负荷（P<0.01）和应用正性肌力药物维持血压（P<0.01）。
More volume loading (P<0.01) and positive inotropic support (P<0.01) were needed to maintain blood pressure in IWMI patients with RVMI.
应用推荐